{
    "laboratory_examinations": [
        {
            "procedure_name": "Complete Blood Count",
            "date": "Not specified",
            "findings": "Negative results",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Sedimentation Rate",
            "date": "Not specified",
            "findings": "Negative results",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Creatinine Phosphokinase Level",
            "date": "Not specified",
            "findings": "Negative results",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Liver Function Tests",
            "date": "Not specified",
            "findings": "Negative results",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Triglyceride Level",
            "date": "Not specified",
            "findings": "2.4 mmol/L (212 mg/dL)",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Hemoglobin Level",
            "date": "Not specified",
            "findings": "17.9%",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Punch Biopsy",
            "date": "Not specified",
            "findings": "Neuropathic process affecting small-caliber sensory nerve fibers",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Prothrombin Time",
            "date": "Not specified",
            "findings": "Decreased after FVIIa therapy",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "International Normalized Ratio",
            "date": "Not specified",
            "findings": "Decreased after FVIIa therapy",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Proteinuria",
            "date": "Not specified",
            "findings": "Patient 1: Decreased from 1.73 g/d to 0.58 g/d; Patient 2: Decreased from 1.60 g/d to 1.04 g/d",
            "changes_over_time": "Discontinuation of spironolactone led to an increase in proteinuria"
        },
        {
            "procedure_name": "Plasma Aldosterone Concentration",
            "date": "Not specified",
            "findings": "Patient 1: Increased from <56 pmol/L to 225 pmol/L; Patient 2: Increased from <56 pmol/L to 69 pmol/L",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "HDL Cholesterol Level",
            "date": "Not specified",
            "findings": "Patient 1: Increased from 0.39 mmol/L (15 mg/dL) to 1.06 mmol/L (41 mg/dL); Patient 2: Decreased from 0.26 mmol/L (10 mg/dL) to 0.26 mmol/L (10 mg/dL) when treated with fenoﬁbrate",
            "changes_over_time": "Patient 1: Increased with atorvastatin; Patient 2: Rebounded with atorvastatin"
        }
    ]
}